Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Limonene analogue XR-3054 is a novel protein farnesyltransferase inhibitor

Aug. 11, 1999

PD-184352 inhibits growth of colon tumors in mice via interference with MAPK pathway

Aug. 11, 1999

Licensing opportunity from NIH: NAT modulators for enhancing efficacy, reducing toxicity of drugs

Aug. 11, 1999

Idec and NCI form partnership to broaden use of ibritumomab tiuxetan

Aug. 10, 1999

Licensing opportunity from NIH: improved technology for radiotherapy of cancer and other diseases

Aug. 10, 1999

Korean researchers synthesize anticancer platinum complexes

Aug. 10, 1999

NCI scientists initiate testing of thalidomide in colorectal cancer patients

Aug. 10, 1999

SCRAS team evaluates topoisomerase inhibitors for cancer indications

Aug. 10, 1999

Phase Ia results reported for Cell Pathways' novel SAAND

Aug. 10, 1999

Takeda scientists synthesize and evaluate GnRH antagonists

Aug. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...